rhBMP-2 is safe and improves outcomes in open tibial fractures .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2014;2(9):25 J Bone Joint Surg Am. 2002 Dec;84-A(12):2123-34450 patients with an open tibial fracture were randomized to receive the standard of care with either intramedullary nail fixation and routine soft-tissue management (the control group), an implant containing 0.75 mg/mL of rhBMP-2 alongside the standard care, or an implant containing 1.50 mg/mL of rhBMP-2 alongside the standard care. The rhBMP-2 implant was placed over the fracture at the time of wound closure. At 12 months, the 1.50-mg/mL rhBMP-2 group had a 44% reduction in the risk of failure, significantly fewer invasive interventions and hardware failures, faster wound-healing and significantly faster fracture healing than the control patients. .
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
